Sprint Bioscience Competitors and Similar CompaniesClear all
Sprint Bioscience's competitors and similar companies include Epizyme and Loxo Oncology.
 Sprint Bioscience Sprint Bioscience is a pharmaceutical company focused on developing drugs to fight cancer. |  Epizyme Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors. |  Loxo Oncology Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations. | |
Founding Date | Founding Date 2009 | Founding Date 2007 | Founding Date 2013 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Huddinge, SE HQ | Locations Cambridge, US HQ | Locations Stamford, US HQ Alcobendas, ES Boulder, US New York, US South San Francisco, US |
Employees | Employees 38 | Employees 20364% increase | Employees 65610% decrease |
Valuation ($) | Valuation ($) 13.8 m | Valuation ($) 250.8 m | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) kr167.2m (FY, 2025) | Revenue (est.) $37.4m (FY, 2021) | Revenue (est.) N/A |
Cost of goods | Cost of goods kr13.1m (FY, 2025) | Cost of goods $10.5m (FY, 2021) | Cost of goods N/A |
Net income | Net income kr91.7m (FY, 2025) | Net income ($251.1m) (FY, 2021) | Net income ($148.9m) (FY, 2017) |
Funding | |||
Total funding raised | Total funding raised $ 5.4m | Total funding raised $ 51.5m | Total funding raised $ 57m |
For sources of this data, please see the company profile
View Company Profiles
Epizyme
HQ
Cambridge, US
Employees
203
Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.
View companyLoxo Oncology
HQ
Stamford, US
Loxo Oncology is a biopharmaceutical company focused on targeted cancer therapies for genetically-defined patient populations.
View company